Detailed price information for Cooper Companies (COO-Q) from The Globe and Mail including charting and trades.

Women’s-health-focused pharma Organon is grabbing exclusive global licensing rights to Sebela Pharmaceuticals’ newly approved hormone-free copper intrauterine device in a deal potentially worth more ...

U.S. District Chief Judge Leigh Martin May of the Northern District of Georgia planned a hearing Tuesday on whether to move ahead with the bellwether plan after a federal jury sided with defendant ...

Goldman Ismail’s Shayna Cook and Rami Fakhouri secured a full defense verdict from federal jurors in Atlanta in the first case from more than 3,800 plaintiffs claiming the Paragard contraceptive ...

Teva faces over 3,800 lawsuits over Paragard IUD claims Trial was the first bellwether to test the claims Teva sold Paragard to CooperSurgical in 2017 Feb 4 (Reuters) - A jury in Atlanta federal court ...

Judge rejects Teva's request to pause trial for appeal 3,800 lawsuits claim Paragard IUD can break during removal First bellwether trial begins January 20 Jan 12 (Reuters) - Teva Pharmaceuticals can’t ...

The MarketWatch News Department was not involved in the creation of this content. Parker Waichman, a national law firm, has now filed multiple lawsuits where each Plaintiff alleges injuries due to ...

Paragard is a brand-name intrauterine device (IUD) used to help prevent pregnancy. Its active ingredient is copper. Paragard is not safe to use during pregnancy but can be used while breastfeeding.

Eight years ago, after Donald Trump won the election, there was a 21.6% increase in the number of IUD insertions. On the day the Supreme Court overturned Roe v. Wade in 2022, IUD appointments ...

Findings showed successful placement of Paragard with the first insertion attempt occurred in 91% of participants. The Food and Drug Administration (FDA) has approved a single-hand inserter for ...